DRNA

DRNA Stock: The $3B Novo Nordisk Deal That Has Dicerna Pharma Shares Skyrocketing Today

By William White, InvestorPlace Writer
Dicerna Pharmaceuticals (DRNA) stock is surging higher on Thursday following news of a massive $3.3 billion deal with Novo Nordisk.

5 Strong Buy Biotech Stocks for the Second Half

By Harriet Lefton, Writer, TipRanks
We are now approaching the second half of 2019. And it may be time for a little portfolio rebalancing. Biotech stocks often move independently from the market, and these 5 are worth a look.